SCHEMBL23914440

SCHEMBL23914440

COc1ccc([C@H]2OC(=O)C(CN(C)C)[C@H]2c2ccc(OC)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
HTT P42858 1/20 0.42
BLM P54132 1/20 0.42
CBS P35520 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
TP53 P04637 1/20 0.39
MAOA P21397 1/20 0.39
PTGS2 P35354 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914069 0.96 ALDH1A1 (0.41) MAPTKMT2AMEN1POLBTHRB
SCHEMBL23914420 0.96 ALDH1A1 (0.41) MAPTKMT2AMEN1POLBTHRB
SCHEMBL23914063 0.95 MAPT (0.39) MAPTKMT2AMEN1POLBTHRB
SCHEMBL23914089 0.95 MAPT (0.39) MAPTKMT2AMEN1POLBTHRB
SCHEMBL23913779 0.90 SLC6A4 (0.39) MAPTKMT2AMEN1POLBTHRB
SCHEMBL23914259 0.90 SLC6A4 (0.39) MAPTKMT2AMEN1POLBTHRB
SCHEMBL23914401 0.84 ALDH1A1 (0.35) KMT2AMEN1SLC6A2SLC6A4SLC6A3
SCHEMBL23914312 0.83 CTRB1 (0.35) KMT2AMEN1SLC6A2SLC6A4SLC6A3
SCHEMBL23914311 0.83 CTRB1 (0.35) KMT2AMEN1SLC6A2SLC6A4SLC6A3
SCHEMBL23914260 0.80 HDAC4 (0.39) MAPTKMT2AMEN1MAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS MIF, LTA, MGAM MAPT 3922/4885KMT2A 2354/4885MEN1 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.